A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4
Clinical trial NCT07052682 · TERMINATED
Trial details
- NCT number
- NCT07052682
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-12-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.